Download Published Manuscripts Updated: February 2013

Published Manuscripts
Updated: February 2013
2013
Dewitt, EM, Li Y, Curtis JR, Glick HA, Greenberg JD, Anstrom KJ, Kremer JM, Reed G, Schulman
KA, Reed SD. Comparative Effectiveness of Nonbiologic versus Biologic Disease Modifying
Antirheumatic Drugs for Rheumatoid Arthritis. J Rheumatol. 2013 Jan 15. [Epub ahead of print]
Diego D, Kurreeman F, Stahl EA, Liao KP, Gupta N, Greenberg JD, Rivas MA, Hickey B, Flannick J,
Thomson B, Guiducci C, Ripke S, Adzhubev I, Barton A, Kremer JM, Aldfredsson L; Consortium of
Rheumatology Researchers of North America; Rheumatoid Arthritis Consortium International,
Sunyaev S, Martin J, Zhernakova A, Bowes J, Eyre S, Siminovitch KA, Gregersen PK, Worthington
J, Klareskog L, Padyukov L, Raychaudhuri S, Plenge RM. Rare, Low-Frequency, and Common
Varients in the Protein-Coding Sequence of Biological Candidate Genes from GWASs
Contribute to Risk of Rheumatoid Arthritis. Am J Hum Genet. 2013 Jan 10;92(1):15-27. doi:
10.1016/j.ajhg.2012.11.012. Epub 2012 Dec 20.
Sarsour K, Greenberg JD, Johnston JA, Nelson DR, O’Brien LA, Oddoux C, Ostrer H, Pearlman A,
Reed G. The Role of the FcGRIIIa Polymorphism in Modifying the Association Between
Treatment and Outcome in Patients with Rheumatoid Arthritis Treated with Rituximab Versus
TNF-α antagonist therapies. Clin Exp Rheumatol. 2012 Dec 13. [Epub ahead of print]
2012
Pappas DA, Oh C, Plenge RM, Kremer JM, Greenberg JD. Association of Rheumatoid Arthritis
Risk Alleles with Response to Anti-TNF Biologics: Results from the CORRONA Registry and
Meta-analysis. Inflammation. 2012 Sep 25. [Epub ahead of print] PubMed PMID: 23007924.
Greenberg JD, Reed G, Decktor D, Harrold L, Furst D, Gibofsky A, Dehoratius R, Kishimoto M,
Kremer JM; CORRONA Investigators. A comparative effectiveness study of adalimumab,
etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients:
results from the US CORRONA registry. Ann Rheum Dis. 2012 Jul;71(7):1134-42. Epub 2012 Jan
30. PubMed PMID: 22294625.
Jawaheer D, Messing S, Reed G, Ranganath VK, Kremer JM, Louie JS, Khanna D, Greenberg JD,
Furst DE. Significance of sex in achieving sustained remission in the Consortium of
Rheumatology Researchers of North America cohort of rheumatoid arthritis patients
Arthritis Care Res (Hoboken). 2012 Jun 21. doi: 10.1002/acr.21762. [Epub ahead of print]
PubMed PMID: 22730408.
Fisher MC, Hochberg MC, El-Taha M, Kremer JM, Peng C, Greenberg JD; CORRONA Investigators.
Smoking, smoking cessation, and disease activity in a large cohort of patients with rheumatoid
arthritis. J Rheumatol. 2012 May;39(5):904-9. Epub 2012 Mar 15. PubMed PMID: 22422494.
Fisher MC, Furer V, Hochberg MC, Greenberg JD, Kremer JM, Curtis JR,Reed G, Harrold L,
Solomon DH. Malignancy validation in a United States registry of rheumatoid arthritis
patients. BMC Musculoskelet Disord. 2012 May 31;13:85.
Harrold LR, Harrington JT, Curtis JR, Furst DE, Bentley MJ, Shan Y, Reed G, Kremer J, Greenberg
JD. Prescribing practices in a US cohort of rheumatoid arthritis patients before and after
publication of the American College of Rheumatology treatment recommendations. Arthritis
Rheum. 2012 Mar;64(3):630-8. doi: 10.1002/art.33380. PubMed PMID: 21953645; PubMed
Central PMCID: PMC3253907.
2011
Anandarajah AP, El-Taha M, Peng C, Reed G, Greenberg JD, Ritchlin CT. Association between
focal erosions and generalized bone loss in psoriatic arthritis. Ann Rheum Dis. 2011
Jul;70(7):1345-7. Epub 2011 Feb 16.
Au K, Reed GW, Curtis JR, Kremer JM, Greenberg JD, Strand V, Furst DE. High disease activity is
associated with an increased risk of infection in patients with rheumatoid arthritis. Ann
Rheum Dis. 2011 May;70(5):785-791. Epub 2011 Feb 2.
Furst DE, Pangan AL, Harrold LR, Chang H, Reed G, Kremer JM, Greenberg JD. Greater likelihood
of remission in rheumatoid arthritis patients treated earlier in the disease course: results from
the consortium of rheumatology researchers of North America registry. Arthritis Care Res
(Hoboken). 2011 Jun;63(6):856-64.
Greenberg JD, Kremer JM, Curtis JR, Hochberg MC, Reed GW, Tsao P, Farkouh ME, Nasir A,
Setoguchi S, Solomon DH. Tumor necrosis factor antagonist use and associated risk reduction
of cardiovascular events among patients with rheumatoid arthritis. Ann Rheum Dis. 2011
Apr;70(4):576-582. Epub 2010 Nov 24.
Zhang J, Shan Y, Reed G, Kremer J, Greenberg JD, Baumgartner S, Curtis JR: Thresholds in
disease activity for switching biologics in rheumatoid arthritis patients: experience from a
large U.S. cohort. Arthritis care & research 2011, 63(12):1672-1679.
2010
Reddy S, Anandarajah A, Fisher M, Mease P, Greenberg J, Kremer J, Reed G, Chen R, Messing S,
Kaukenien, K, Ritchlin CT. Comparative analysis of disease activity measures using biologic
agents, BMI, Radiographic Features, and Bone Density in Psoriatic Arthritis and Rheumatoid
Arthritis Patients Followed in a Large US Disease Registry. Journal of Rheumatology. 2010 Dec;
37(12): 2566-72.
Sokolove J, Strand V, Greenberg JD, Curtis JR, Kavanaugh A, Kremer JM, Anofrei A, Reed R,
Calabrese L, Hooper M, Baumgertner S, and Furst D. Risk of elevated liver enzymes associated
with TNF inhibitor utilization in patients with rheumatoid arthritis. Ann Rheum Dis. 2010 Sep;
69(9): 1612-7.
Curtis JR, Jain A, Askling J, et al. A comparison of patient characteristics and outcomes in
selected European and U.S. rheumatoid arthritis registries. Seminars in arthritis and
rheumatism. Aug 2010;40(1):2-14 e11.
Bentley MJ, Greenberg JD, Reed GW. A modified rheumatoid arthritis disease activity score
without acute-phase reactants (mDAS28) for epidemiological research. J Rheumatology. 2010
Aug 1;37(8):1607-14
Solomon DH, Kremer JM, Curtis JR, Hochberg M, Reed G, Tsao P, Farkouh M, Setoguch S, and
Greenberg JD. Explaining the cardiovascular risk associated with rheumatoid arthritis:
traditional Risk Factors Versus Markers of Rheumatoid Arthritis Severity. Ann Rheum Dis.
2010 Nov;69(11):1920-5. Epub 2010 May 5.
Greenberg JD, Reed G, Kremer JM, Tindall E, Kavanaugh A, Zheng C, Bishai W, Hochberg M.
Association of methotrexate and tumor necrosis factor antagonists with risk of infectious
outcomes including opportunistic infections in the CORRONA registry. Ann Rheum Dis. 2010
Feb;69(2):380-6.
Curtis JR, Chen L, Harrold LR, Narongroeknawin P, Reed G, Solomon DH. Physician preference
motivates the use of anti-tumor necrosis factor therapy independent of clinical disease
activity. Arthritis Care Res. 2010 Jan 15;62(1):101-7.
Curtis JR, Beukelman T, Onofrei A, Strand V, Greenberg JD, Reed G, Kremer JM.
Elevated liver enzyme tests among patients with rheumatoid arthritis or
psoriatic arthritis treated with methotrexate and/or leflunomide. Annals of Rheumatic
Disease 2010 Jan; 69(1):43-7.
2009
Kremer JM, Greenberg JD. Interpreting registry derived drug studies: does societal context
matter? Arthritis Rheum. 2009 Nov; 60(11):3155-7.
Curtis JR, Patkar NM, Jain A, Greenberg J, Solomon DH. The validity of physician-reported
hospitalized infections in an observational U.S. arthritis registry. Rheumatology (Oxford) 2009
October; 48(10):1269-72.
Lee SJ, Chang H, Yazici Y, Greenberg JD, Kremer JM, Kavanaugh A. Utilization trends of tumor
necrosis factor inhibitors among rheumatoid arthritis patients in a United States observational
cohort study. J Rheumatol. 2009 Aug; 36(8):1611-7.
Furst D, Chang H, Greenberg J, Ranganath V, Reed G, Ozturk Z, Kremer JM. Prevalence of low
hemoglobin levels and associations with other disease parameters in rheumatoid arthritis
patients: Evidence from the CORRONA registry. Clin Exp Rheumatol. 2009 Jul-Aug;27(4): 560-6.
Greenberg JD, Fisher MC, Kremer JM, Chang H, Rosenstein ED, Kishimoto M, Lee S, Yazici Y,
Kavanaugh A, Abramson SB. The COX-2 inhibitor market withdrawals and prescribing patterns
by rheumatologists in patients with gastrointestinal and cardiovascular risk. Clin Exp
Rheumatol. 2009 May-Jun; 27(3):395-401.
Greenberg JD, Harrold LR, Bentley MJ, Kremer JM, Reed G. Strand V. Evaluation of composite
measures of treatment response without acute phase reactants in patients with rheumatoid
arthritis. Rheumatology (Oxford). 2009 June; 48(6):686-90
Coulson KA, Reed G, Gilliam BE, Kremer JM, Pepmueller PH. Factors influencing fracture risk, T
score, and management of osteoporosis in patients with rheumatoid arthritis in the
Consortium of Rheumatology Researchers of North America (CORRONA) registry. J Clin
Rheumatol. 2009 Jun;15(4):155-60.
2008
Aizer J, Reed G, Onofrei A, Harrison MJ. Predictors of bone density testing in patients with
rheumatoid arthritis. Rheumatology international. Jun 2009;29(8):897-90
Ranganath VK, Paulus HE, Onofrei A, Khanna D, Reed G, Elashoff DA, Kremer JM, Furst DE.
Functional improvement after patients with rheumatoid arthritis start a new disease
modifying antirheumatic drug (DMARD) associated with frequent changes in DMARD: the
CORRONA database. J Rheumatol. 2008 Oct;35(10):1966-71.
Greenberg JD, Kishimoto M, Strand V, Cohen SB, Olenginski TP, Harrington JT, Kafka SP, Reed G,
Kremer JM. TNF antagonist responsiveness in a United States rheumatoid arthritis cohort. Am
J Med. 2008 June;121(6):532-538.
Kremer JM, Gibofsky A, Greenberg JD. The role of drug and disease registries in rheumatic
disease epidemiology. Current Opinion in Rheumatology. 2008 March;20(2):123–130.
2006
Tutuncu Z, Reed G, Kremer JM, Kavanaugh A. Do patients with older-onset rheumatoid
arthritis receive less aggressive treatment? Ann Rheum Dis. 2006 Sep;65(9):1226-1229
Greenberg JD, Bingham CO, Abramson SB, Reed G, Kishimoto M, Hinkle K, Kremer
JM. Assessment of coxib utilization by rheumatologists for nonsteroidal antiinflammatory
drug gastroprotection prior to the coxib market withdrawals. Arthritis Rheum (Arthritis Care
and Research), Aug 2006;55(4):543-50.
Kremer JM. The CORRONA Database. Autoimmun Rev. 2006 Jan;5(1):46-54.
2005
Kremer JM. The CORRONA Database. Ann Rheum Dis. 2005 Nov;64 Suppl 4:iv37-41.
Kremer JM. The CORRONA Database. Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S172-7.
Greenberg JD, Bingham CO, Abramson SB, Reed G, Seibaldt R, Kremer JM. Effect of
cardiovascular comorbidities and concomitant aspirin use onselection of cyclooxgenase
inhibitor among rheumatologists. Arthritis Rheum (Arthritis Care and Research), 2005
Feb;53:12-17
2003
Sebaldt RJ, Kremer JM. CANDOO and CANOAR, CORRONA and more: advancing therapeutics
through layered-in clinical data collection and feedback at the point of care. The Journal of
rheumatology. Nov 2003;30(11):2308-2311.